References
- Sadovnikova E, Jopling LA, Soo KS, Stauss HJ. Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. Eur. J. Immunol. 28(1), 193–200 (1998).
- Hunter T, Pines J. Cyclins and cancer. Cell 66(6), 1071–1074 (1991).
- De Falco M, De Luca A. Cell cycle as a target of antineoplastic drugs. Curr. Pharm. Des. 16(12), 1417–1426 (2010).
- Kao H, Marto JA, Hoffmann TK et al. Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J. Exp. Med. 194(9), 1313–1323 (2001).
- Sarita Rajender P, Ramasree D, Bhargavi K, Vasavi M, Uma V. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer – a review. J. Recept Signal Transduct Res. 30(4), 206–213 (2010).
- von Bergwelt-Baildon MS, Kondo E, Klein-González N, Wendtner CM. The cyclins: a family of widely expressed tumor antigens? Expert Rev. Vaccines 10(3), 389–395 (2011).
- Ratschiller D, Heighway J, Gugger M et al. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J. Clin. Oncol. 21(11), 2085–2093 (2003).
- Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L, Lam WL. Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias. Int. J. Cancer 125(9), 2219–2228 (2009).
- Rasmussen T, Kuehl M, Lodahl M, Johnsen HE, Dahl IM. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood 105(1), 317–323 (2005).
- Horree N, Heintz AP, Sie-Go DM, van Diest PJ. p16 is consistently expressed in endometrial tubal metaplasia. Cell. Oncol. 29(1), 37–45 (2007).
- Covini G, Chan EK, Nishioka M, Morshed SA, Reed SI, Tan EM. Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology 25(1), 75–80 (1997).
- Suzuki H, Graziano DF, McKolanis J, Finn OJ. T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease. Clin. Cancer Res. 11(4), 1521–1526 (2005).
- Kondo E, Maecker B, Draube A et al. The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells. Int. J. Cancer 125(10), 2474–2478 (2009).
- Wang M, Sun L, Qian J et al. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy. Leukemia 23(7), 1320–1328 (2009).
- Kao H, Marto JA, Hoffmann TK et al. Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J. Exp. Med. 194(9), 1313–1323 (2001).
- Sørensen RB, Andersen RS, Svane IM et al. CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53. Clin. Cancer Res. 15(5), 1543–1549 (2009).
- Kondo E, Gryschok L, Schultze JL, von Bergwelt-Baildon MS. Using CD40-activated B cells to efficiently identify epitopes of tumor antigens. J. Immunother. 32(2), 157–160 (2009).
- Vella LA, Yu M, Fuhrmann SR, El-Amine M, Epperson DE, Finn OJ. Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer. Proc. Natl Acad. Sci. USA 106(33), 14010–14015 (2009).
- Andersen RS, Sørensen RB, Ritter C et al. Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors. Cancer Immunol. Immunother. 60(2), 227–234 (2011).
- Ochsenreither S, Majeti R, Schmitt T et al. Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood 119(23), 5492–5501 (2012).
- Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell. Mol. Life Sci. 59(8), 1317–1326 (2002).
- Michalides R, van Tinteren H, Balkenende A et al. Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br. J. Cancer 86(3), 402–408 (2002).
- Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int. J. Cancer 84(3), 225–233 (1999).
- Yang R, Nakamaki T, Lübbert M et al. Cyclin A1 expression in leukemia and normal hematopoietic cells. Blood 93(6), 2067–2074 (1999).
- Leisenfelder SA, Moffat JF. Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity. J. Virol. 80(11), 5577–5587 (2006).
- Sanchez V, Spector DH. Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles. J. Virol. 80(12), 5886–5896 (2006).
Website
- National Center for Biotechnology Information (NCBI) Blast. http://blast.ncbi.nlm.nih.gov/Blast.cgi